In 2008, Hodgson-Zingman et al. 7 reported a genetic mutation in the atrial natriuretic peptide gene, NPPA, in a large family with atrial fibrillation (AF), and demonstrated the novel observation of the effects of this neuro-hormone on the action potential of atrial myocardium. Here, NPPA is linked to atrial fibrillation.